MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
13.17
+0.05 (0.38%)
Aug 21, 2026, 11:23 AM EDT - Market open

MediWound Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, MediWound stock has a consensus rating of "Strong Buy" and an average price target of $29.83. The average 1-year stock price forecast is 126.59% higher than the current stock price, while the lowest is $22 (+67.11%) and the highest is $36 (+173.45%).

Price Target: $29.83 (+126.59%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$22$29.83$30$36
Change+67.11%+126.59%+127.88%+173.45%

Analyst Ratings

The average analyst rating for MediWound stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingJan '26Mar '26Apr '26May '26Jun '26Aug '26
Strong Buy555555
Buy111111
Hold000000
Sell000000
Strong Sell000000
Total666666

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Maxim Group
Maxim Group
Buy
Reiterates
$30
BuyReiterates$30+127.88%Aug 15, 2026
Oppenheimer
Oppenheimer
Buy
Maintains
$32$30
BuyMaintains$32$30+127.88%Aug 14, 2026
TD Cowen
TD Cowen
Buy
Reiterates
$25
BuyReiterates$25+89.90%Aug 14, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Maintains
$36
BuyMaintains$36+173.45%Aug 14, 2026
Alliance Global Partners
Alliance Global Partners
Buy
Maintains
$22
BuyMaintains$22+67.11%Aug 13, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
23.67M
from 16.96M
Increased by 39.60%
Revenue Next Year
31.81M
from 23.67M
Increased by 34.34%
EPS This Year
-2.23
from -2.10
EPS Next Year
-2.29
from -2.23
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
23.76M26.50M18.69M20.22M16.96M23.67M
Revenue Growth
9.19%11.50%-29.48%8.22%-16.14%39.60%
Gross Profit
8.77M13.17M3.58M2.63M3.25M4.69M
Gross Margin
36.91%49.69%19.15%13.03%19.19%19.82%
Operating Income
-11.22M-7.66M-15.50M-19.40M-25.27M-35.79M
Net Income
-13.55M-19.60M-6.72M-30.22M-23.88M-29.11M
EPS
-----2.10-2.23
Free Cash Flow
-1.36M-8.82M-3.05M-6.59M-15.58M-37.80M
No. Analysts
-----6
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High25.3M
Avg23.7M
Low21.1M

Revenue Growth

Revenue Growth202620272028
High
49.3%
Avg
39.6%
Low
24.3%

EPS Forecast

EPS202620272028
High-1.98
Avg-2.23
Low-2.71

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-